about
Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein.The inflammatory protein Pentraxin 3 in cardiovascular diseaseVacuolar Protein Sorting Genes in Parkinson's Disease: A Re-appraisal of Mutations Detection Rate and Neurobiology of DiseaseThe Monoamine Brainstem Reticular Formation as a Paradigm for Re-Defining Various Phenotypes of Parkinson's Disease Owing Genetic and Anatomical Specificity.Activation of mGlu3 receptors stimulates the production of GDNF in striatal neurons.Changes of peripheral TGF-β1 depend on monocytes-derived macrophages in Huntington diseaseInduction of the Wnt antagonist Dickkopf-1 is involved in stress-induced hippocampal damage.Monomeric ß-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons.Overexpression of alpha-synuclein following methamphetamine: is it good or bad?Genetic or pharmacological blockade of noradrenaline synthesis enhances the neurochemical, behavioral, and neurotoxic effects of methamphetamine.The Wnt antagonist, Dickkopf-1, as a target for the treatment of neurodegenerative disorders.Early defect of transforming growth factor β1 formation in Huntington's disease.Intracellular pathways underlying the effects of lithium.A Decrease of Brain MicroRNA-122 Level Is an Early Marker of Cerebrovascular Disease in the Stroke-Prone Spontaneously Hypertensive Rat.The Autophagoproteasome a Novel Cell Clearing Organelle in Baseline and Stimulated Conditions.Neurons other than motor neurons in motor neuron disease.Methamphetamine increases Prion Protein and induces dopamine-dependent expression of protease resistant PrPsc.Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.Dickkopf-3 Upregulates VEGF in Cultured Human Endothelial Cells by Activating Activin Receptor-Like Kinase 1 (ALK1) Pathway.The Neuroanatomy of the Reticular Nucleus Locus Coeruleus in Alzheimer's DiseaseTransglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders.The origin recognition complex subunit, ORC3, is developmentally regulated and supports the expression of biochemical markers of neuronal maturation in cultured cerebellar granule cells.Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation.Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice.Continuous subcutaneous infusion of apomorphine rescues nigro-striatal dopaminergic terminals following MPTP injection in mice.Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.PHCCC, a specific enhancer of type 4 metabotropic glutamate receptors, reduces proliferation and promotes differentiation of cerebellar granule cell neuroprecursors.Tumor necrosis factor-alpha mediates hemolysis-induced vasoconstriction and the cerebral vasospasm evoked by subarachnoid hemorrhage.Region-specific DNA alterations in focally induced seizures.A small dose of apomorphine counteracts the deleterious effects of middle cerebral artery occlusion in different models.High number of striatal dopaminergic neurons during early postnatal development: correlation analysis with dopaminergic fibers.Occurrence of neuronal inclusions combined with increased nigral expression of alpha-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice.TGF-beta 1 protects against Abeta-neurotoxicity via the phosphatidylinositol-3-kinase pathway.Enhanced tau phosphorylation in the hippocampus of mice treated with 3,4-methylenedioxymethamphetamine ("Ecstasy").Previous exposure to (+/-) 3,4-methylenedioxymethamphetamine produces long-lasting alteration in limbic brain excitability measured by electroencephalogram spectrum analysis, brain metabolism and seizure susceptibility.Systematic Morphometry of Catecholamine Nuclei in the Brainstem.The nature of catecholamine-containing neurons in the enteric nervous system in relationship with organogenesis, normal human anatomy and neurodegeneration.5-HT(2C) serotonin receptor blockade prevents tau protein hyperphosphorylation and corrects the defect in hippocampal synaptic plasticity caused by a combination of environmental stressors in mice.Mechanisms involved in the formation of dopamine-induced intracellular bodies within striatal neurons.Pharmacological activation of mGlu4 metabotropic glutamate receptors reduces nigrostriatal degeneration in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
P50
Q26269955-3544FE53-5EA5-4042-AFB3-6F0BC5CE13F3Q26738957-6F6D6343-D12D-477F-9ED4-85FA109AFB4CQ28074841-B78F88B8-1A89-41BD-9F5B-415CADC17838Q30357944-5D3964FF-29E2-4326-9749-5CFB8E4FCB26Q33492743-65BC8DEB-00BB-4858-AC9A-5FDB2CE19422Q33644718-3555E92C-F93B-4B73-BB25-8BFB75AD6ADBQ33815184-9FDCA8A7-6AAD-4E84-BFE5-430E38097BB9Q35925948-A9E593B4-4591-4CAE-A4B7-AFD08FB04C3DQ36653961-936629DF-181F-4A50-9B91-F5E3D6AF0B04Q37029888-E32E9F7E-84D3-47ED-A5C7-8F08E0981CA0Q37144218-B57C43F1-F55A-496E-99A6-77DDD583CC40Q37580232-B6E4D4F2-125B-41D8-9242-64128FF9B27DQ37779225-BB4B26B9-D77A-4B05-AAB6-E4E805F68DA9Q38656292-76D4112A-551E-4BAB-8FD4-5A2356A7AAA2Q38753705-F2C7CF91-91DF-4DF4-AAFD-9159802ECC10Q39233485-489EC8BB-7FB8-433C-9B17-134DC961D512Q40131895-82D4E877-9A95-4D42-B7B0-238A3E4ACA2CQ42166995-CF26CDAE-E23F-44DA-95B8-34444AD5830FQ42316713-869E521B-8210-425D-985E-667129095022Q42363053-41F3D60F-E010-4AD3-B72B-83A1C3231FF1Q42503234-8EF85993-26CF-4496-8AA6-5022F5DA6738Q42950711-D8B8F140-98CE-4BA6-8FEA-7CEE784A1F84Q42958588-450036D7-E617-4352-B1FD-B10E3B5A7BD0Q43782014-FDBEEF43-AB8A-45EC-AA5C-020FBF357111Q43919475-A142ACB7-F2F5-49C6-A1E2-FD82DB9B577FQ44746550-F6570011-19DB-4C3D-ADD8-26105E945218Q45153510-642D4B6E-EECB-48AC-AF2D-E9E3C81C4125Q45995798-DFB8E307-CE8A-446B-88E3-8000DA1CE51BQ46175550-46F5D63E-271E-4654-B4DB-F7E0696FA857Q46245110-9BF6777E-F49E-432E-9F57-B13DC26A022FQ46402614-E78A56D9-AD20-428E-B93E-62C3BA4590B1Q46440075-AF3F9263-A3D1-49BB-A605-8387D46863D0Q46690418-E96C5E63-FF81-4A9F-AF24-7E9128A18114Q46691801-C7307E50-9563-45BA-8843-CAA3E8C40898Q46734631-1D1F200B-BFD8-4F2D-8C06-C515E3DF91ECQ47166544-98705AAC-40E5-4404-A6AC-98BF22AEC549Q47926128-2974FA1E-85E4-4133-A1D7-617CAF4C55A8Q48094003-B7587B5B-EDC2-4054-B3D5-B9951A25AA04Q48280499-FDAE3E7D-62AF-4E35-8DBE-968E4E5D1DCDQ48478225-A5161280-D1C7-4D01-A5AC-3E895BBFA233
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Carla L Busceti
@ast
Carla L Busceti
@en
Carla L Busceti
@es
Carla L Busceti
@nl
type
label
Carla L Busceti
@ast
Carla L Busceti
@en
Carla L Busceti
@es
Carla L Busceti
@nl
prefLabel
Carla L Busceti
@ast
Carla L Busceti
@en
Carla L Busceti
@es
Carla L Busceti
@nl
P106
P1153
6602627545
P21
P31
P496
0000-0002-1417-1893